Search for: "Wright Manufacturing Inc" Results 121 - 140 of 209
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Jun 2012, 10:33 am
The FDA has asked manufacturers like Johnson & Johnson, Zimmer Holdings Inc. and Biomet Inc. to conduct long-term, follow-up studies of more than 100 metal-on-metal hips on the U.S. market. [read post]
27 Jun 2012, 10:33 am
The FDA has asked manufacturers like Johnson & Johnson, Zimmer Holdings Inc. and Biomet Inc. to conduct long-term, follow-up studies of more than 100 metal-on-metal hips on the U.S. market. [read post]
25 Jun 2012, 2:01 pm by Brenda Fulmer
The current order for this hearing session includes oral argument or consideration of a number of issues relating to the following existing medical device and drug MDLs: NuvaRing (MDL No. 1964), Asbestos (MDL No. 875), Oxycontin (MDL No. 1603), Prempro (MDL No. 1507), Accutane (MDL No. 1626), Mentor ObTape (MDL No. 2004), Chantix (MDL No. 2092), DePuy ASR Hip Implant (MDL No. 2197), Fosamax (Alendronate Sodium) (MDL No. 2243), DePuy Pinnacle Hip Implant (MDL No. 2244), Zimmer NexGen Knee Implant… [read post]
25 Jun 2012, 2:01 pm by Brenda Fulmer
The current order for this hearing session includes oral argument or consideration of a number of issues relating to the following existing medical device and drug MDLs: NuvaRing (MDL No. 1964), Asbestos (MDL No. 875), Oxycontin (MDL No. 1603), Prempro (MDL No. 1507), Accutane (MDL No. 1626), Mentor ObTape (MDL No. 2004), Chantix (MDL No. 2092), DePuy ASR Hip Implant (MDL No. 2197), Fosamax (Alendronate Sodium) (MDL No. 2243), DePuy Pinnacle Hip Implant (MDL No. 2244), Zimmer NexGen Knee Implant… [read post]
25 Jun 2012, 2:01 pm by Brenda Fulmer
The current order for this hearing session includes oral argument or consideration of a number of issues relating to the following existing medical device and drug MDLs: NuvaRing (MDL No. 1964), Asbestos (MDL No. 875), Oxycontin (MDL No. 1603), Prempro (MDL No. 1507), Accutane (MDL No. 1626), Mentor ObTape (MDL No. 2004), Chantix (MDL No. 2092), DePuy ASR Hip Implant (MDL No. 2197), Fosamax (Alendronate Sodium) (MDL No. 2243), DePuy Pinnacle Hip Implant (MDL No. 2244), Zimmer NexGen Knee Implant… [read post]
17 May 2012, 12:05 pm by Bexis
Wright Medical Technology, Inc., 2012 WL 1681810 (N.D. [read post]
14 May 2012, 8:24 am by Schachtman
  The inanity of “each and every exposure” was not seriously hurtful in the early asbestos litigation, when the defendants were almost all manufacturers of asbestos-containing insulation, and if a manufacturer had supplied insulation to a worksite, then the proportion of asbestos exposure for that manufacturer would likely have been “substantial. [read post]
2 Apr 2012, 10:46 am by ParkerMcDonald
The decision to hold a committee meeting comes almost a year after the FDA issued 145 orders for post market surveillance studies to 21 manufacturers of metal-on-metal hip systems, including Zimmer Holdings, DePuy, Wright Medical, Biomet, and Smith & Nephew. [read post]
2 Apr 2012, 10:34 am by ParkerMcDonald
The decision to hold a committee meeting comes almost a year after the FDA issued 145 orders for post market surveillance studies to 21 manufacturers of metal-on-metal hip systems, including Zimmer Holdings, DePuy, Wright Medical, Biomet, and Smith & Nephew. [read post]
3 Mar 2012, 5:36 pm by Schachtman
Fla., Oct. 29, 1998) Minnesota Mining and Manufacturing v. [read post]
10 Feb 2012, 10:04 am by Robert Oszakiewski
" Among the members of the Steering Committee is John Monica, Jr, a partner in the DC office of Porter, Wright, Morris & Arthur LLP. [read post]
30 Dec 2011, 7:27 am by William McGrath
The Lindsey Manufacturing Saga: The Verdict DOJ was "Fiercely Committed" to Obtaining is Vacated. 1. [read post]
20 Dec 2011, 3:07 pm by Geoffrey Manne
As our colleague, Josh Wright, has thoroughly demonstrated, this “own-content” bias is actually an infrequent phenomenon and is simply not consistent with an actionable claim of anticompetitive foreclosure. [read post]
20 Dec 2011, 2:38 pm by Geoffrey Manne
As our colleague, Josh Wright, has thoroughly demonstrated, this “own-content” bias is actually an infrequent phenomenon and is simply not consistent with an actionable claim of anticompetitive foreclosure. [read post]